Results from PharmAust’s canine cancer trials have shown positive progress in the clinical trials of its primary drug candidate Monepantel.
Pet Industry News is Australia and New Zealand’s leading news service for the pet industry.
Results from PharmAust’s canine cancer trials have shown positive progress in the clinical trials of its primary drug candidate Monepantel.